NCT00138216 2023-10-02Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsChildren's Oncology GroupPhase 1 Completed42 enrolled
NCT00101270 2013-06-05Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed24 enrolled